Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Mechanisms of Retrovirus-induced Cancers

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinoma.

bioRxiv : the preprint server for biology·2026

Same author

NDRG3 is essential for sustaining antigen-driven T cell responses by protecting against restimulation-induced cell death.

Journal of immunology (Baltimore, Md. : 1950)·2026

Same author

Derivation of functional early gestation decidual natural killer cell subtypes from induced pluripotent stem cells.

Stem cells (Dayton, Ohio)·2026

Same author

Publisher Correction: Atlas-guided discovery of transcription factors for T cell programming.

Nature·2026

Same author

The CD8 immgenT framework as a universal reference of mouse CD8αβ T cell differentiation states.

bioRxiv : the preprint server for biology·2026

Same author

Atlas-guided discovery of transcription factors for T cell programming.

Nature·2026

Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026

Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026

Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026

Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026

Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026

Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 25, 2025

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

SnapShot: Cancer immunoediting.

Siva Karthik Varanasi¹, Susan M Kaech¹, Jack D Bui²

¹The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

|October 14, 2022

Summary

This summary is machine-generated.

Cancer immunoediting involves interactions between immune and tumor cells, altering tumor characteristics. This study compares natural and therapy-induced cancer immunoediting, detailing factors influencing tumor regression or progression.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

Related Experiment Videos

Last Updated: Aug 25, 2025

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

Area of Science:

Oncology
Immunology
Cancer Biology

Background:

The tumor microenvironment is a complex ecosystem where tumor cells and immune cells interact.
Cancer immunoediting describes the dynamic interplay between the immune system and cancer cells, influencing tumor evolution.
This process can lead to tumor elimination, a dormant state, or tumor escape and progression.

Purpose of the Study:

To compare endogenous (natural) and therapy-induced cancer immunoediting.
To outline the molecular and cellular mechanisms driving these interactions.
To differentiate factors leading to complete tumor regression versus tumor escape and progression.

Main Methods:

Comparative analysis of molecular and cellular characteristics.
Review of existing literature and data on cancer immunoediting.
Focus on gene expression, metabolism, mutational burden, and cellularity changes.

Main Results:

Distinct molecular and cellular signatures characterize endogenous versus therapy-induced immunoediting.
Specific interactions promote either tumor regression or facilitate tumor escape.
Changes in tumor microenvironment components are critical determinants of outcome.

Conclusions:

Understanding the nuances of cancer immunoediting is crucial for developing effective cancer therapies.
Therapy-induced immunoediting presents unique targets and challenges compared to endogenous processes.
Tailoring therapeutic strategies based on immunoediting dynamics may improve patient outcomes.